|
|
||||||||
Papers In Press, published online ahead of print December 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biochemistry, INSERM U498, Dijon 21034
Corresponding Author: david.masson{at}laposte.net
Abstract Background&aims: Human plasma, unlike mouse plasma contains the cholesteryl ester transfer protein (CETP) that may influence the transport of cholesterol from peripheral tissues to the liver, and its biliary excretion. Liver X receptor (LXR), an oxysterol-activated nuclear receptor induces CETP transcription via a direct repeat (DR) 4 element in the CETP gene promoter. The aim of the study was to assess in vivo the impact of LXR activation on hepatic CETP expression and its consequences in terms of plasma lipid metabolism, hepatic lipid content and biliary cholesterol secretion . Methods: Wild type and humanized mice expressing human CETP under the control of its natural flanking regions were treated for five days with T0901317 LXR agonist. Results: Short-term treatment with the T0901317 LXR agonist produced marked rises in both hepatic CETP mRNA and plasma CETP activity levels (8- and 3-fold, respectively). Interestingly, the LXR agonist-mediated, 2-fold rise in both total and HDL cholesterol levels in treated wild-type mice was not observed in mice expressing human CETP. Whereas liver triglycerides were increased to similar extents in both wild-type and CETPTg mice treated with T0901317, the CETP-mediated accumulation of cholesterol in the liver of CETPTg mice was fully reversed by administration of the LXR agonist. Moreover, LXR activation induced a 2-fold increase in the hepatic LDL-receptor gene expression in both wild-type and CETPTg mice, and it produced a significantly greater rise in biliary cholesterol secretion in CETPTg mice as compared to wild-type mice. Conclusions: The LXR-mediated upregulation of CETP, in conjunction with other proteins involved in reverse cholesterol transport, constitutes a major determinant of the effect of LXR agonist on biliary secretion of cholesterol.
Revised on December 1, 2003
Accepted on December 15, 2003
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Calpe-Berdiel, N. Rotllan, C. Fievet, R. Roig, F. Blanco-Vaca, and J. C. Escola-Gil Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8 J. Lipid Res., September 1, 2008; 49(9): 1904 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Thomassen, B. P. Barna, A. G. Malur, T. L. Bonfield, C. F. Farver, A. Malur, H. Dalrymple, M. S. Kavuru, and M. Febbraio ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis J. Lipid Res., December 1, 2007; 48(12): 2762 - 2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Drouineaud, P. Sagot, C. Garrido, E. Logette, V. Deckert, P. Gambert, C. Jimenez, B. Staels, L. Lagrost, and D. Masson Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists Mol. Hum. Reprod., June 1, 2007; 13(6): 373 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gautier, U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. N. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein J. Lipid Res., January 1, 2007; 48(1): 30 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Masson, L. Lagrost, A. Athias, P. Gambert, C. Brimer-Cline, L. Lan, J. D. Schuetz, E. G. Schuetz, and M. Assem Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid-Mediated Changes in Plasma Lipoprotein Profile Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2164 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Coutinho, R. R. Singaraja, M. Kang, D. J. Arenillas, L. N. Bertram, N. Bissada, B. Staels, J.-C. Fruchart, C. Fievet, A. M. Joseph-George, et al. Complete functional rescue of the ABCA1-/- mouse by human BAC transgenesis J. Lipid Res., June 1, 2005; 46(6): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |